发明名称 1-OXOISOINDOLINE AND 1,3-DIOXOISOINDOLINE SUBSTITUTED OPTIC ISOMERS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATION THEREOF
摘要 <p>Substituted 2-(2,6-dioxopiperidin-3-yl)phtalimides and l-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF alpha in a mammal. Typical embodiments are 1-oxo-2(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline and 1,3-dioxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4-aminoisoindoline.</p>
申请公布号 PL195916(B1) 申请公布日期 2007.11.30
申请号 PL19970373743 申请日期 1997.07.24
申请人 CELGENE CORP. 发明人 MULLER GEORGE W.;STIRLING DAVID I.;CHEN ROGER SHEN-CHU
分类号 C07D401/04;A61K31/4439;A61K31/445;A61K31/454;A61P1/00;A61P1/04;A61P7/00;A61P9/02;A61P9/04;A61P9/10;A61P17/06;A61P19/00;A61P19/02;A61P29/00;A61P31/06;A61P33/06;A61P35/00;A61P37/02;A61P37/06;A61P43/00 主分类号 C07D401/04
代理机构 代理人
主权项
地址